Company announces 8 new license agreements and commencement of $15
million stock repurchase program SANTA ANA, Calif., Nov. 4
/PRNewswire-FirstCall/ -- SRS Labs, Inc. (NASDAQ:SRSL), the
industry leader in surround sound, audio and voice technologies,
reported financial results for the third quarter ended September
30, 2008. The company also has made available for download a slide
presentation of financial data and analysis at
http://www.srslabs.com/pdf/Q308earnings.pdf Recent Developments The
second and third quarters for SRS were eventful and cause for
optimism due to several developments. First is the solid management
team that SRS now has in place, the best in its history. The
Company has always had industry leading engineering talent. Now
that talent has been complemented with new sales and marketing
executives with proven industry credentials that have led to
revamped sales and marketing organizations. Several positive
developments occurred during the past two quarters, including 17
new license agreements with companies such as Hewlett-Packard,
Vizio and NEC computer. Revenue from these newly signed licensees,
along with expected revenue from additional license agreements
anticipated to be signed in the near term, represent forecasted
incremental revenue growth of approximately $7 million for 2009. In
recognition of the deepening recession and uncertainties in the
global marketplace, the Company is taking a conservative approach
in its forecast for 2009 by maintaining our previously stated 25%
revenue growth. There is no historic precedent for the current
recession and therefore no basis to predict how long or how deep it
will be, nor any certainty regarding what the recovery will look
like. In recognition of these uncertainties, SRS is forecasting
revenues that are substantially less than what might otherwise be
forecast in a normal market. Third Quarter Financial Results Net
revenues in the third quarter 2008 totaled $4.3 million, a decrease
of 9% from $4.8 million in the same period a year ago. The decrease
is primarily attributable to changes in the company's home
entertainment segment with three of the Company's larger television
customers. During the quarter, eight new license agreements were
signed which are anticipated to start generating revenues in three
to nine months as SRS technology is integrated into new consumer
products. Operating expenses in the quarter totaled $4.9 million,
an increase of 37% from $3.6 million in the same quarter a year
ago. Of this increase, approximately $500,000 is comprised of
one-time charges related to the company's ongoing investment in
strengthening its sales and marketing departments, and
approximately $179,000 is related to capital transaction
activities. Net loss was $316 thousand or ($0.02) per basic and
diluted share, versus a net income of $1.7 million or $0.10 per
basic and diluted share in the third quarter of 2007. Quarter-end
cash and cash equivalents and short-term and long-term investments
totaled $46.7 million, as compared to $45.4 million at the end of
the same quarter in the prior year. "During the quarter, we secured
several new significant design wins in multiple segments and
geographic regions," said Thomas C.K. Yuen, SRS Lab's Chairman and
CEO. "These wins came primarily as a result of the investments we
are making in broadening the bandwidth and improving the quality of
our sales and marketing departments. More importantly, we have been
able to benefit from the excellent new leadership in both of these
critical areas to motivate and mobilize the respective teams in a
disciplined and results oriented manner. Our sales team continues
to identify new and significant business opportunities in nearly
all of our segments which we believe will lead to healthy revenue
growth in 2009." Yuen continued, "Due to the progress we are
experiencing, I am happy to announce today that our board of
directors has approved a new stock repurchase program under which
we may acquire up to $15 million of our outstanding common stock
for a period of up to six months commencing on November 7, 2008."
Conference Call SRS Labs will hold a conference call later today
(November 4, 2008) to discuss these third quarter 2008 financial
results. Chairman and CEO, Thomas C.K. Yuen, and CFO, Ulrich
Gottschling, will host the call starting at 5:00 p.m. Eastern Time.
A question and answer session will follow management's
presentation. Dial-In Number: 1-800-862-9098 International:
1-785-424-1051 Conference ID#: 7SRS The conference call will be
broadcast simultaneously and available for replay via the investor
section of the company's website at http://www.srslabs.com/. Please
call the conference telephone number 5-10 minutes prior to the
start time. An operator will register your name and organization
and ask you to wait until the call begins. If you have any
difficulty connecting with the conference call, please contact the
Liolios Group at 949-574-3860. A replay of the call will be
available after 8:00 p.m. Eastern Time that same day and until
November 18, 2008 at: Toll-free replay number: 1-800-388-5895
International replay number: 1-402-220-1110 (No passcode required)
About SRS Labs, Inc. Founded in 1993, SRS Labs is the industry
leader in audio signal processing for consumer electronics.
Beginning with the audio technologies originally developed at
Hughes Aircraft, SRS Labs holds over 150 worldwide patents and is
recognized by the industry as the foremost authority in research
and application of human auditory principals. Through partnerships
with leading global CE companies, semiconductor manufacturers and
software partners, SRS audio, surround sound and voice processing
technologies have been included in over one billion electronic
products sold worldwide including HDTVs, mobile phones, portable
media devices, PCs and automotive entertainment. In fact, SRS Labs
is the de-facto standard of HDTV audio processing with nine of the
top ten name brand flat panel TVs featuring SRS technology.
Additionally, SRS Labs surround sound solutions provide the
professional broadcast and recording industries with
high-performance production, back-haul, storage, and transmission
capability. SRS Labs supports manufacturers worldwide with offices
in the US, China, Europe, Japan, Korea and Taiwan. For more
information, visit http://www.srslabs.com/. Safe Harbor Statement
This press release includes forward-looking statements that are
based on our current expectations, estimates and projections about
SRS Labs, Inc., management's beliefs and certain assumptions made
by us, and events beyond our control, all of which are subject to
change. Such forward-looking statements include, but are not
limited to, statements relating to our future growth opportunities,
expansion and investment plans, operating results and
profitability, as well as the stock repurchase program.
Forward-looking statements can often be identified by words such as
"expects," "anticipates," "intends," "plans," "predicts,"
"believes," "seeks," "estimates," "may," "will," "should," "would,"
"could," "likely," "potential," "continue," similar expressions,
and variations or negatives of these words. These forward-looking
statements are not guarantees of future results or the commitments
made by us herein, and they are subject to risks, uncertainties and
assumptions that could cause actual results to differ materially
and adversely from those expressed in any forward-looking
statement. The risks and uncertainties referred to above include,
but are not limited to, the timely development, release and market
acceptance of new SRS Labs' products and technologies, the impact
of competitive products, technologies and pricing; the loss of any
material customer, design win or license arrangement; the ability
of our customers to gain broad market acceptance for products
incorporating our technologies and the timing of our customers'
sales; our ability to quickly and cost-effectively respond to
technological changes and advancements; intellectual property
disputes and the impact of pending litigation; the effectiveness of
our expense and cost control and reduction efforts; general
economic and political conditions and specific conditions in the
markets we address; and such other factors described in our filings
with the Securities and Exchange Commission. The forward-looking
statements in this press release speak only as of the date they are
made. We do not undertake any obligation to revise or update
publicly any forward-looking statement for any reason. Company
Contacts: Ulrich Gottschling Chief Financial Officer SRS Labs, Inc.
Tel 949-442-5596 Matt Glover Investor Relations Liolios Group Tel
949-574-3860 SRS LABS, INC. AND SUBSIDIARY CONDENSED CONSOLIDATED
BALANCE SHEETS September 30, December 31, 2008 2007 (unaudited)
ASSETS Current Assets Cash and cash equivalents $41,733,491
$39,615,291 Accounts receivable, net 569,503 1,138,425 Prepaid
expenses and other current Assets 833,099 893,388 Short-term
investments 4,984,000 - Total Current Assets 48,120,093 41,647,104
Investments available for sale - 5,451,875 Property and equipment,
net 360,561 309,727 Intangible assets, net 2,321,642 2,197,616
Deferred income taxes, net 2,986,421 1,776,202 Total Assets
$53,788,717 $51,382,524 LIABILITIES AND STOCKHOLDERS' EQUITY
Current Liabilities Accounts payable $546,912 $529,063 Accrued
liabilities 959,748 689,308 Deferred revenue 1,802,999 1,156,836
Total Current Liabilities 3,309,659 2,375,207 Commitments and
Contingencies Stockholders' Equity Preferred stock --$.001 par
value; 2,000,000 shares authorized; no shares issued or outstanding
- - Common stock --$.001 par value; 56,000,000 shares authorized;
15,796,777 and 16,946,377 shares issued; and 15,782,577 and
15,778,715 shares outstanding at September 30, 2008 and December
31, 2007, respectively 15,798 16,947 Additional paid-in capital
69,582,396 74,143,772 Accumulated other comprehensive loss -
(48,125) Accumulated deficit (19,021,532) (19,155,096) Treasury
stock at cost, 14,200 and 1,167,662 shares at September 30, 2008
and December 31, 2007, respectively (97,604) (5,950,181) Total
Stockholders' Equity 50,479,058 49,007,317 Total Liabilities and
Stockholders' Equity $53,788,717 $51,382,524 SRS LABS, INC. AND
SUBSIDIARY CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED) Three Months Ended Nine Months Ended September 30,
September 30, 2008 2007 2008 2007 Revenues $4,319,433 $4,769,271
$13,438,565 $14,536,526 Cost of sales 22,107 36,850 88,426 115,912
Gross margin 4,297,326 4,732,421 13,350,139 14,420,614 Operating
expenses*: Sales and marketing 2,451,026 1,460,185 7,078,563
5,104,195 Research and development 948,305 689,901 2,727,837
2,366,121 General and administrative 1,524,529 1,436,184 4,490,485
4,105,792 Total operating expenses 4,923,860 3,586,270 14,296,885
11,576,108 Operating (loss) income (626,534) 1,146,151 (946,746)
2,844,506 Interest income 310,219 508,825 1,093,543 1,511,585
(Loss)income before income taxes (316,315) 1,654,976 146,797
4,356,091 Income taxes - (18,800) 13,233 (18,800) Net (loss) income
$(316,315) $1,673,776 $133,564 $4,374,891 Net (loss) income per
common share: Basic $(0.02) $0.10 $0.01 $0.27 Diluted $(0.02) $0.10
$0.01 $0.26 Weighted average shares used in the calculation of net
income (loss) per common share: Basic 15,779,486 16,268,524
15,778,493 16,160,970 Diluted 15,779,486 16,978,841 16,249,158
17,100,334 *Included in Q3 2008 total operating expenses is
stock-based compensation expense of $425,191; $111,751 in sales and
marketing, $85,734 in research and development, and $227,706 in
general and administrative expenses. Included in Q3 2007 total
operating expenses is stock-based compensation expense of $438,050;
$112,162 in sales and marketing, $108,987 in research and
development, and $216,901 in general and administrative expenses.
DATASOURCE: SRS Labs, Inc. CONTACT: Ulrich Gottschling, Chief
Financial Officer of SRS Labs, Inc., +1-949-442-5596, ; or Matt
Glover, Investor Relations of Liolios Group, +1-949-574-3860, , for
SRS Labs, Inc. Web Site: http://www.srslabs.com/
Copyright
Srs Labs (NASDAQ:SRSL)
Historical Stock Chart
From Jun 2024 to Jul 2024
Srs Labs (NASDAQ:SRSL)
Historical Stock Chart
From Jul 2023 to Jul 2024